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Summary 
The primary roles of T cells and B cells in the initiation of systemic autoimmunity are unclear. 
To investigate the role of B ceils, we crossed the "Jh knockout" mutation onto the autoimmune 
Ipr/Ipr background. Animals homozygous for both traits were obtained. As expected, these animals 
lack B cells. These animals also show no signs of autoimmune kidney destruction nor vasculitis, 
in spite of carrying the lpr/Ipr mutation. In contrast, lpr/Ipr littermates that had B cells had severe 
nephritis and vasculitis, as well as autoantibodies. These results demonstrate a primary role for 
B cells and/or (auto)antibodies in initiating several types of autoimmune-mediated  tissue destruction. 
The implications of this finding for models and therapy of autoimmunity are discussed. 
S 
Ystemic autoimmune diseases are the result of complex 
interactions among T cells, B cells, and target tissues. How- 
ever, it has been difficult to distinguish the contributions of 
each cell type in both the initiation of the autoimmune re- 
sponse and the induction of specific pathologic lesions. This 
is in large part because the dependence of B cell activation 
on T cells and, reciprocally,  the ability of B cells to act as 
potent APC for T  cells. 
Evidence of direct roles of T cells and B cells (or secreted 
Ig) in human lupus has been largely circumstantial. Examples 
include the presence of T cells in lesions or the presence of 
autoantibody at sites of inflammation (1-3). Animal models, 
on the other hand, have provided direct evidence for a role 
of both cell types (4-8).  Intrinsic T  cell defects have been 
dearly shown in Ipr (9), BXSB, and NZB-based (10) models. 
Furthermore, in autoimmune MRL mice homozygous for 
the Ipr mutation, thymectomy (11), anti-Thyl (12), or anti- 
CD4 (13) antibody treatment ameliorates lymphoprolifera- 
tion and delaYs autoimmune-mediated  inflammation. T cells 
have also been observed within lesions of affected organs (14), 
most notably within  the  renal  interstitium,  surrounding 
vessels, and, to a lesser extent, glomeruli of MRL-Ipr/lpr mice, 
coincident with the development of nephritis (8,  15). 
There is also evidence of a primary role for autoantibodies 
and B cells in autoimmune pathogenesis. For example, some 
but not all anti-DNA antibodies cause nephritis upon injec- 
tion  into  normal  mice  (6,  16,  17), whereas  certain  RF 
cryoglobulins (particularly of the IgG3 subclass) cause vas- 
culitis and nephritis upon injection (18, 19). The role of B 
cells in initiating autoimmunity, perhaps by priming or ex- 
panding autoreactive T cells, is less clear. Using immuniza- 
tion of normal mice with cross-reactive  variants of self-proteins, 
Lin et al. and Mamula et al. (20,  21) have suggested a key 
role for B cells in initiating T  cell autoreactivity followed 
by a cascade of additional B cell autoreactivity. B cells from 
both Ipr/Ipr and NZB mice are intrinsically prone to autoan- 
tibody secretion (22-25).  However, genetic studies have sepa- 
rated the secretion of certain autoantibodies from autoim- 
mune manifestations, indicating that the role of B cells may 
be complex (26,  27). 
Experiments using strategies to inactivate B cells have sug- 
gested their importance in autoimmunity. NZB.xid mice, 
which have developmentally arrested B cells owing to the 
xid defect, have a milder form of disease than their NZB coun- 
terparts (10). Similarly, C57Bl/6-1pr/lpr  mice, treated with 
anti-IgM from birth, had few B cells and minimal glomeru- 
lonephritis; systemic vasculitis was unaffected (28). However, 
because anti-IgM treatment may have effects aside from reduc- 
tion orb cells, genetic approaches would be helpful to deter- 
mine whether Ig, B cells, or both are required for disease 
expression. 
For this purpose, the lpr/Ipr model of autoimmunity (29, 
30) is ideal because fulminant autoimmunity and accumula- 
tion of abnormal T cells (31, 32) are controlled by a single 
recessive gene. Genetic studies are further facilitated by the 
recent discovery that Ipr is a mutation in theJ~s gene (33). 
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for apoptosis (33, 34) has important implications for Ipr/lpr 
autoimmunity. However, how a global J~s defect causes au- 
toimmunity remains unclear, in part becausefas is expressed 
in many cell types and its regulation is activation dependent 
(35,  36).  Thus, further work on the cellular contributions 
to autoimmunity in Ipr/lpr mice is required. 
To examine the role of B cells in lpr-induced  autoimmu- 
nity, in the current studies we have used a novel genetic 
approach whereby Ipr/Ipr mice were deprived of B cells from 
birth without exogenous manipulation. We found that these 
lpr/Ipr mice that lacked B cells failed to develop nephritis or 
vasculitis.  Thus B cells and/or antibody play an important 
role in the initiation of a wide variety of autoimmune mani- 
festations in lpr/1pr mice. 
Materials and Methods 
Mice 
Jh knockout mice were produced as described (37) and had back- 
ground genes of 129/Sv and C57B1/6 origin. Mice carrying a single 
mutant  Jh allele  were intercrossed at an early stage of propagation, 
and homozygous mice were identified by PCR assay (see below). 
These mice were maintained usually by brother-sister rantings. 
Henceforth, the mutated Jh allele will be referred to as JhD. F1 
mice were produced from two separate matings of these homozy- 
gousJhD mice with MR.L l lpr/lpr mice. The MR.blprAlor mice were 
bred at Fox Chase Cancer Center (Phihdelphia,  PA) from an original 
breeding pair obtained from The Jackson Laboratory (Bar Harbor, 
ME). Three separate 1:2 crosses were set up at the same time. These 
mice were analyzed at 4.5-6 mo of age, as indicated in the tables 
and figures. 
Genetic  Testing 
A dual-primer pair PCR assay  was used to type for heavy-chain 
locus genotype. One pair of primers was specific  for the Neo gene. 
These primers were Neo 5' (5'CCTIGCGCAGCTG'IGCTCGAC- 
GTTG 3') and Neo 3' (5'GCCGCATIGCATCAGCCATGATC,  GA 
3'). A second  pair of  primers amplified  a region of the locus deleted 
by the gene targeting Jh 5' (5'GGACCA~AGGTCAC- 
TCAGG 3') andJh 3' (5' GAGGAGACGGTGACCGTGGTCCCT- 
GC 3'). Tail DNA preparation and PCR were carried out essen- 
tially as described (38). PCR buffer contained 2.5 mM MgCh. 
The following thermal cycler  temperature program was used: 94~ 
l-rain initial denaturation; and then 30 cycles of 94~  30 s/65~ 
30 s/72~  30 s, followed by 2 min at 72~  (MJ Research, Water- 
town, MA). Mice positive in both assays  were considered hetero- 
zygotes, whereas mice positive in only one assay  were considered 
homozygotes. FACS  ~ analysis  agreed with genotyping in all cases 
tested. A Southern blot assay  was used to detect the lpr mutation, 
using the 180-bp Xba-RI fragment spanning the 5' end of thetis 
eDNA (33) as a probe. As expected, homozygous mutant mice 
had a smaller EcoRI fragment than wild-type mice, whereas bet- 
erozygotes had both bands at about half  the homozygote intensity. 
Lymphoproliferation  occurred in all mice typed as lpr/Ipr with this 
assay  with the exception  of  a single  mouse (see Results). This mouse 
also lacked  double  negative  T ceils. Retyping by Southern  blot clearly 
showed this mouse to be a heterozygote. 
FACS | 
Cell Preparation.  Bone  marrow (BM)  x from a single femur was 
harvested from the first cohort of mice by fushing the marrow 
cavities with staining medium (RPMI 1640 deficient  in biotin and 
lacking phenol red, supplemented with 2.5% FCS and 0.04% so- 
dium azide). Spleens, thymi, and inguinal LN were harvested  from 
all mice, and single-cell  suspensions  were prepared. After washing, 
~5-20  x  10  s cells were included in staining reactions, which were 
performed  as described  (39). LN were weighed  in both experiments. 
Spleens were weighed in the second experiment only; the large 
size of the spleens from the older Ipr/llor mice precluded disruption 
of entire spleens via our standard procedure. Therefore, a few rep- 
resentative portions were severed and disrupted. 
Staining.  The following mAbs were used in this study: 331.3 
(40; anti-IgM), RA3-6B2 (41; anti-B220), 30H12 (42; anti-Thyl.2), 
and 53.7 (42; anti-Lyl.1). GIO.5 (43; anti-CD4) and 53.6 (42; anti- 
CDS) were prepared and kindly provided by N. Reutsch in the 
laboratory of M. Bosma  (Fox Chase Cancer Center). 50AA12 (anti- 
CD3; PE conjugated)  was purchased  from PharMingen (San  Diego, 
CA) and provided by N. Reutsch. Multicolor FACS  |  analysis  was 
performed on a FACstar  Plus (Becton Dickinson & Co., Mountain 
View, CA) equipped with dual hsers. 50,000 ungated events were 
collected. In all plots, dead cells were excluded from analysis by 
staining with propidium iodide. IL-rcentages  given of cells in var- 
ious FACS  |  gates are of live cells. 
Kidney Analysis 
Histology.  Kidney sections from each animal were analyzed by 
direct immunofluorescence  and light microscopy,  as previously  de- 
scribed (6,  44). For direct immunofluorescence, fluoresceinated 
subclass-specific antisera were used, and the intensity of fluores- 
cence was graded on a scale from 0 to 3 +  for the presence and 
quantity of immune deposits (45). For fight microscopy, one en- 
tire kidney from each animal was fixed in 10% formalin and em- 
bedded in paraffin. Multiple 4-/~m sections through the center of 
the longitudinal axis of each whole kidney were obtained, and they 
were stained with hematoxylin and eosin. 
Microscopic Evaluation.  The sections were evaluated  by one of 
us (M. P. Madaio) without knowledge of the donor mouse geno- 
type. The severity  of  disease in each compartment (glomerular, in- 
terstitial, vascular) was graded on semiquantitative scoring of bi- 
opsy features (0-3 +) according to previously described methods 
of  Austin et al. (46), used in the analysis  of  human lupus nephritis. 
For purposes of grading in this study, 5-6-too-old MRDlpr/~vr  mice 
with severe disease and 2-too-old normal CBA/J mice were used 
for comparison (defined as 3 +  and 0, respectively).  Morphologic 
analysis  involved  assessment of the following: (a) for glomerulone- 
phritis:  glomerular  hyperceLlnlarity  (including glomerulm  cell 
proliferation, leukocyte exudation),  karyorrhexis and  fibrinoid 
necrosis, luminal occulusion, and cellular crescents; (b) for intersti- 
tial nephritis: infiltration of mononudear cells, loss of normal ar- 
chitecture, and tubular necrosis; and (c) for vasculitis: perivascular 
infiltrates, intimal hyperplasia, and hmiual occuhision. 
ELISA~ for Ig and RF 
ELISA assays  were performed as previously  described (38). Stan- 
dard titrations were done on each plate, and concentrations were 
t Abbreviations  used in thispaper:  BM, bone marrow; DN, double  negative 
for CD4 and CD8; FL, fluorescein;  SP, single  positive  for CD4 or CDS. 
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4.5-mo-old mice  5.5-6-mo-old mice 
Genotype"  CD4 § /  Total cell  CD4 § /  Total cell 
DN  CD8-  count  LN  DN  CDS-  count  LN 
lpr  Jh  n  T  ceils*  T  ceils  ( X 107) $  weight  n  T  ceils  T  ceils  ( X 107)  weight 
rag  mg 
+ / +  + / +  1  26  47  0.1  8  1  6  59  0.2  5 
+ / +  -  / -  1  4  58  5.3  16  1  9  36  0.4  4 
1/I  +/+  2  72 (12)  15  (5)  4.8 (4.1)  85 (48)  1  87  7  40  292 
1/1  +/-  2  63  (19)  20 (8)  2.2 (1.5)  55  (30)  5  84 (4)  10  (2)  23  (9.6)  537 (277) 
1/1  -/-  3  78 (12)  13 (7)  17  (9.1)  113  (41)  3  74 (6)  13  (2)  4  (1.6)  59 (34) 
Numbers are percentages of live lymphocytes, rounded to the nearest whole number. When multiple mice have been analyzed in a group, the SEM 
is given in parentheses. 
" Genotype was determined by Southern blot for Ipr and PCR for Jh loci. +, wild-type allele; 1, Ipr mutant allele; -, inactivated Jh locus allele. 
* DN T cell values are percentages of total T ceUs (as determined by CD3 or Thyl expression in multicolor staining) to fadlitate direct comparison 
of mice with and without  B ceils. 
S Total number of nucleated cells recovered from two inguinal LN. 
estimated by comparison to curves fitted to standard  values by use 
of a four-parameter curve fit on semilog plots. 
Results 
Analysis ofF2 Progeny and Experimental Design.  F2 mice 
provided all possible genotypic combinations.  The genetic 
background of these mice was half MILL and half from the 
Jh background,  which was itself a  mixture of 129/Sv and 
C57B1/6.  Individual background genes segregate indepen- 
dently of Jh and Ipr types in such crosses and  thus  should 
not induce a bias between  the groups,  except  those genes 
closely linked  to the Jh  and lpr loci themselves. 
From 3 F1 males crossed to 9 F1 females, 81 F2 progeny 
were genotyped. The distribution of the nine possible geno- 
types (not shown) does not differ from the expected frequency 
(p  --  0.86,  X  2, eight degrees of freedom).  Two cohorts of 
mice, each Containing three mice of the lpr/lprJhDIJhD geno- 
type along with randomly chosen individuals of other geno- 
types, were analyzed, the first at 4.5 mo and the second at 
Table  2.  Analysis of Spleens 
Genotype" 
4.5-mo-old mice  5.5-6-mo-old mice 
DN  B220§  B220+/  Total cell count  DN  B220+/  B220+/  Spleen 
lpr  Jh  n  T  cells*  Thyl +  Thyl -  ( x  107)s  n  T  ceils.  Thyl +  Thyl-  weight 
rag 
+ / +  + / +  1  12  1  59  7  1  29  21  44  77 
+ / +  -  / -  1  13  1  3  6  1  11  7  3  53 
1/1  +/+  2  56  (8)  22  (9)  43  (14)  33 (19)  1  68  37  25  605 
1/1  +/-  2  40 (12)  16  (4)  43 (2)  27 (13)  5  68 (5)  28  (10)  20 (7)  1,475  (566) 
1/1  -/-  3  64 (6)  39 (1)  7  (3)  6  (2)  3  67 (3)  42 (2)  4  (1)  108  (3) 
Numbers are percentages of live lymphocytes, rounded to the nearest whole number. When multiple mice have been analyzed in a group, the SEM 
is given in parentheses. 
" Genotype was determined by Southern blot for lpr and PCK for Jh loci. +, wild-type allele; 1, lpr mutant allele; -, inactivated Jh locus allele. 
* DN T cell values are percentages of total T cells (as determined by CD3 or Thyl expression in multicolor staining) to facilitate direct comparison 
of mice with and without B cens. 
s Total number of nucleated cells recovered from the whole spleen. This was determined only for the 4.5-mo-old mice. Spleen weight was deter- 
mined for the second cohort. 
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for autoantibodies and renal disease;  nine were also subjects 
of FACS  |  analysis.  In the second cohort,  14 mice were ana- 
lyzed, 12 by FACS  |  as well. The data from the two cohorts 
are presented  separately in the tables. 
Peripheral Lymphoid Organs.  Lymphadenopathy was ob- 
served in LN of all lpr/Ipr mice (Table 1). Among the younger 
cohort  of mice,  lymphadenopathy  (both  weight  and  cell 
number) was similar regardless of whether mice lacked B cells. 
However, in the older cohort, lymphadenopathy was more 
severe among mice that had B cells. Spleens of the 4.5-mo- 
old Ipr/Ipr mice that had B cells contained r  more cells 
on average than mice heterozygous for Ipr or +/+  mice (Table 
2). Spleen weight averaged 15-fold higher in the older (5.5-6 
mo) Ipr/Ipr mice with B cells. Thus, for splenomegaly,  a differ- 
ence was already apparent in the younger cohort, but it be- 
came more pronounced in the older cohort, whereas a differ- 
ence in LN hyperplasia was apparent only among the older 
cohort of B cell-containing Ipr/lpr mice. That lymphoaccumu- 
lation fails to progress with age in Ipr/lpr mice lacking B cells 
suggests a role for B cells in augmenting the accumulation 
of Ipr/Ipr T  cells. 
Phenotypes of Peripheral Lymphoid Cells.  lpr/lpr mice >4 mo 
are known to harbor large numbers of T cells with unusual 
phenotypes.  The  majority  of  these  are  Thyl+/CD3a"ll/ 
B220a"/CD4-/CD8-,  termed  double  negative  (DN)  T 
cells (32). Lymphoaccumulation also includes an increase in 
the absolute numbers of CD4 + and CD8 §  single positive 
(SP) cells,  although  to a lesser  degree. Since B cells are re- 
quired for efficient priming of T cells during immunization 
(47, 48), we investigated by FACS  |  whether the absence of 
B cells would affect T  cell accumulation.  As shown in Fig. 
co 
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Figure  1.  FACS  analysis  of CD4 and CD8 e~- 
pression in CD3 + LN cells of 4.5-mo-old mice. 
Single cell  suspensions of inguinal LN  were 
stained with fluorescein (FL)-anti-CDS, PE-anti- 
CD3, and allophyencyanin anti-CD4, followed 
by multicolor FACS  ~ analysis. Shown are 5% 
probability  plots  from representative animals. 
Only live cells (unstained with propidium iodide) 
with forward and side scatter characteristics of 
lympliocytes that  were  positive  for  CD3  are 
shown. Genotypes of the animals are as follows: 
(A and B) Ipr/Ipr  JhD/JhD; (C and D) lpr/lpr 
+/+; (E)  +/+ JhD/JhD; and (F)  +/+  +/+. 
Percentages of total CD3 § cells in quadrants are 
given in each panel. Note the increased  frequency 
of CD4-/CD8 -  T cells in Ipr mice. Animal-to- 
animal  variability in DN T cell frequency is typ- 
ical at this early stage of disease. 
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proportions of these cells in LN or spleen. Whether defined 
as Thyl + or CD3 + cells,  there were no differences in the 
proportions of DN, CD4 +, or CD8 + SP T cell subsets.  In 
addition, there were similar frequencies of cells that were dull 
for Thyl, CD3, and B220 (Fig. 2 and Tables 1 and 2). Thus 
the presence of B cells does not affect the proportional na- 
ture of lymphoproliferation caused by the homozygous Ipr 
mutation. However, because the number of accumulated cells 
was greater in Ipr/lpr mice that  had  B cells,  the absolute 
numbers of both DN and SP T  cells were greater in such 
mice than in Ipr/lpr mice lacking B cells. This was particu- 
larly evident in the oldest cohort of mice tested. 
We also performed staining with anti-B220 and anti-IgM 
to enumerate B cells. As revealed by bright anti-B220 staining 
and (in the second cohort) anti-IgM staining, mature B cells 
were present only in those mice genotyped as heterozygous 
or wild type at theJh locus (Fig. 2 and Tables 1 and 2). Some 
Ipr/Ipr mice with a wild-type Jh allele had a relatively small 
proportion of splenic B cells, presumably due to extensive 
T  cell accumulation. However, in all such Ipr/Ipr mice, the 
absolute number of splenic B cells was increased. 
Two curiosities were noted in the FACS  ~ experiments. First, 
in some Ipr/IprJhD/JhD  mice, a small population of B220  a~ 
Thyl- cells was found in LN (data not shown). Three-color 
staining with anti-Thyl, anti-IgM, and anti-B220 staining 
in  the  second  experiment  showed  that  these  cells  were 
slgM-.  Thus, these cells may have reflected seeding of the 
LN by pre-B cells, which do develop in JhD mice (37, our 
unpublished  data).  However,  similar cells  have also  been 
reported in previous studies of lpr/Ipr mice; it was speculated 
that such cells are in the T lineage (49).  This latter conclu- 
sion is consistent with the observation in separate staining 
reactions that nearly all lymphoid cells from the same LN 
were CD3 + (data not shown). Further muhicolor staining 
will be required to define the lineage of these cells. 
Second, we noted in a single +/+  +/+  mouse a popula- 
tion of cells staining brightly for CD3 and B220 (Fig. 2 D). 
These B220+/CD3 + cells  also  stained with anti-IgM but 
not anti-Thyl. Thus, they probably represent B cells. The 
reason for the bright CD3 staining is unclear; it does not 
represent  reagent  interaction,  as  most  B220 +  cells  were 
negative for CD3.  It is possible that a subpopulation of B 
cells expressed high levels of FcR, which bound the anti-CD3 
antibody. Unfortunately, because of the experimental design, 
it was not possible  to repeat the staining with different re- 
agents  and  controls.  Since  cells  falling  in  the  B220b~ig  h' 
CD3 + area were IgM + Thyl- in Fig. 2 D but IgM- Thyl + 
in Fig. 2, A  and B, we gated on the B220  a~ CD3 a~n popu- 
lation characteristic of DN T cells to quantitate comparable 
cell populations in each mouse. 
Central Lymphoid Organs.  Single-cell suspensions derived 
from thymi and BM were examined by FACS  |  Similar quan- 
tities of thymic cells were recovered from all mice. lpr/lF mice 
with  B  cells  had  higher  proportions  of  CD4-/CD8- 
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Fig,~ 2.  F^cs  ￿9 analysis  of  B220 
and CD3 expression on splenocytes 
of  5.5-too-old  mice.  Cells  were 
stained with FL-anti-B220 and PE- 
anti-CD3. Gating and plots are as 
in Fig. t. The Ipr andJh genotypes 
of the animals are as follows: (A) 
lpr/lpr JhD/JhD; (B) Ipr/lpr  JhD/ + ; 
(c) +/+ JhD/JhD; and (D) +/+ 
+/+. Note the virtual absence of 
B220b~ht/CD3 -  B  cells (lower 
right box in each panel) in the JhD/ 
JhD animals (A and C). The upper 
left bo~ in each panel shows a popu- 
lation  of  B220a~/CD3  a~u  cells. 
These cells are rare in +/+ mice (C 
and D) but are common in Ipr/Ipr 
mice (A and B), and accumulate in 
similar proportions regardless  of the 
Jh genotype (compare A  and B). 
The population of cells brighter for 
both CD3 and B220 seen in A and 
B likely comprises an additional ab- 
normal population of T cells. See 
text for details. The 3% of B220 + 
cells in A and C do not express IgM 
(not shown) and thus resemble  pre-B 
cells. 
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Figure 3.  FACS analysis  of 
CD4 and CD8 expression among 
Thyl + thymocytes  of 4.5-mo-old 
mic~ Single-cell suspensions were 
stained with biotin anti-Thyl, FL- 
anti-CD8, and allophycocyanin- 
anti-CD4, followed  by ~  Paxl- 
avidin. Gating and plots are as in 
Fig.  1.  Percentages  of  total 
Thyl + cells are given for each 
quadrant. In all thymi, >96% of 
live lymphocytes were Thyl+. 
The Ipr and Jh genotypes of the 
animals are as follows: (A) Ipr/lpr 
JhD/JhD; (B) lpr/Ipr +/+; (C) 
+/+  JhD/JhD;  and (D)  +/+ 
+/+. Note the large fraction of 
DN Thyl + cells in  the Ipr/lpr 
+/+  animal (B) not present in 
any of the other genotypes. The 
thymi of the mice used for A and 
B yielded similar numbers of  total 
ceils. 
Table 3). The proportion of DN thymocytes in Ipr/Ipr mice 
with B cells was also higher than in  +/+  littermates  with 
or without B cells.  The nature of these excess  DN thymo- 
cytes, which have been previously observed in Ipr/Ipr mice, 
is somewhat uncertain (49-51). They may represent DN ab- 
normal T  cells, which were also found in larger numbers in 
peripheral lymphoid organs of the older lpr/Ipr mice that had 
B cells. It is unlikely that these are B cells since thymic profiles 
Table  3.  Analysis  of Thymus 
4.5-mo-old mice  5.5-6-mo-old mice 
Genotype*  CD4 § /  CD8 § /  CD4 § /  CD4 § /  CD8 § /  CD4 § / 
DN T  CD8-  CD4-  CD8 §  DN T  CD8-  CD4-  CD8 § 
1pr  Jh  n  cells  T  cells  T  cells  T  cells  n  cells  T  cells  T  cells  T  cells 
+/+  +/+  1  4  13  11  72  1  2  10  6  82 
+/+  -/-  1  5  10  50  33  1  2  10  7  82 
1/1  +/+  2  15  (8)  15 (2)  15  (5)  55  (1)  1  26  23  8  41 
1/1  +/-  2  19 (12)  23  (13)  19 (7)  39 (32  i  5  34 (9)  21  (3)  11  (1)  33 (9) 
1/1  -/-  3  2  (0)  14 (2)  12  (0)  71  (2)  3  3  (0)  13  (1)  10 (2)  74 (2) 
Numbers are percentages of live lymphocytes, rounded to the nearest whole number. When multiple mice have been analyzed in a group, the SEM 
is given in parentheses. Percentages are of T lymphocytes as determined by gating on Thyl as a third color. 
* Genotype was determined by Southern blot for lpr and PCR for Jh loci. +, wild-type allele; 1, lpr mutant allele; -, inactivated Jh locus allele. 
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ally >95% of live calls). The significance of the B cell de- 
pendence ofDN thymic T cells is discussed  below. BM staining 
for B220 and anti-IgM was performed on the first cohort 
of mice and revealed no differences in the proportions ofpre- 
B (i.e., B220'~/IgM -) or B (B220*/IgM +) phenotype cells 
between Ipr/Ipr and heterozygous or  +/+  mice (data not 
shown). As expected, mice homozyguus for the JhD muta- 
tion lacked mature (B220t~  h=) or immature (13220  'ha) slgM + 
B cells, although most had detectable pre-B cells (data not 
shown). 
AutoantibodyProduction.  Serum RF activity as well as serum 
IgG1 and K levels were measured in all mice (Fig. 4). As ex- 
pected, mice that lacked B cells lacked serum RF and Ig. lpr/llrr 
animals with B cells had markedly devated Ig and RF levels 
compared with mice with B calls but homozygous for Ipr. 
Elevations of RF (two to five orders of magnitude compared 
with non-lpr controls) were proportionally much greater than 
general hypergammaglobulinemia (about one order of mag- 
nitude of elevation;  see Fig.  4),  consistent  with antigen- 
sdective autoantibody production in Ipr/Ipr mice (52). Thus, 
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Figure 4.  Serum Ig and R.F levels. Levels of serum ~ (top), K-positive 
anti-IgG2a (middle) and IgG1 (bottom) were determined. The different age 
cohorts  are represented separately  (10q and right columns).  Each  point 
represents a single mouse. Mice are divided by Ipr or Jh genotype, which 
is given at the bottom of the figure. I/l, Ipr/Ipr; or +/+, wild type; -/-, 
homozygous Jh deletion;  +/+,  homozygous wild type;  +/-,  hereto- 
zygotes. 
age-related lpr/ltrr-controlled autoantibody production resem- 
bling that of MRL-lpr/Ipr  mice had ensued among the co- 
horts of F2 mice. 
Nephritis and Vasculitis.  Renal pathology was interpreted 
without knowledge of mouse genotypes. The mice could be 
readily distinguished into two groups with strikingly different 
morphologies: a group with normal architecture and no im- 
mune deposits and a group with severe glomerulonephritis, 
interstitial nephritis, vasculitis, and both glomerular and in- 
terstitial  immune deposits.  Representative  examples are il- 
lustrated  in Fig. 5. Details  of the pathology are described 
in the legends. Severe nephritis always segregated with the 
presence of both the Ipr/lpr genotype and B cells, and this 
was observed for all animals in both cohorts (a total of 10 
lpr/Ipr mice with B cells). By contrast, none of the six Ipr/lpr 
mice that lacked B cells and circulating Ig developed nephritis; 
their histology was indistinguishable from the four +/+ lit- 
termates that had B cells and with normal control CBA/J 
mice. 
Discusaion 
To further elucidate the role of B cells in MRL-lpr/lpr mice, 
a series ofF2 mice were created from crosses oflpr/lpr homo- 
zygotes  and mice homozygous for a mutation 0hD) that 
prevents development of mature B cells. Strikingly,  in the 
absence of B cells, lpr/Ipr mice developed neither glomerulo- 
nephritis, vasculitis, nor interstitial nephritis. In contrast, all 
of the lpr/lpr littermate mice with B cells developed severe 
nephritis and autoantibodies.  These results indicate that B 
cells and/or autoantibodies  play a primary role in the initia- 
tion of lupus nephritis in this genetic background. Severe 
nephritis was present in B cell-containing lpr//pr mice at 4 mo 
of age, a time when lymphoaccumulation was equivalent in 
mice lacking B cells and animals with B cells. Thus, suppres- 
sion of nephritis was not the result of decreased lymphoac- 
cumulation.  For  each  form  of nephritis  observed  in  B 
cell-sufficient  mice, it is formally possible that the role of 
B cells is as (auto)antibody-forming cell precursors, as APC 
in causing T cell activation,  or both. However, likely roles 
of B cells for each form of nephritis are suggested by previous 
work on pathogenesis. 
The requirement of B calls for induction of glomerulone- 
phritis substantiates previous work suggesting a role of im- 
mune deposits in glomerulonephritis (1, 5, 6, 16-18, 45) and 
indicates that immune deposit formation is likely a pivotal 
event in the initiation of the glomerular lesion. Furthermore, 
although other systemic and local cellular and cytokine per- 
turbations are present in these animals (53, 54), they are by 
themselves insufficient to induce even microscopic  disease. 
In this regard,  it will be of particular interest  to evaluate 
cytokine levels within the glomeruli of mice lacking B ceils 
to determine the influence of B calls and Ig deposition on 
cytokine disregulation reported to occur before the onset of 
overt disease (54). 
Absence of interstitial  nephritis in Ipr/lpr mice lacking B 
cells is also interesting and surprising,  particularly because 
1301  Shlomchik et al. Figure  5.  Histologic evaluation of kidneys from Ipr/Ipr mice (hematoxylin and eosin stained). R~presentative sections are presented to illustrate severe 
glomerulonephritis, vasculitis, and interstitial nephritis, which were present in all lpr/lpr  mice with B cells in both age groups (n  z  10). (A) lpr/lpr 
mouse without B cells at 5.5 mo of age (x 400). The histology is normal. (B-F) Ipr/Ipr mice with B calls (x 400). (B and C) Proliferative glomerulone- 
phritis with mild interstitial hypercellularity.  (D) Perivasculitis  (intense).  (E) Glomerulonephritis, perivasculitis,  and interstitial nephritis. (F) Severe 
interstitial nephritis with tubular necrosis. 
of the hypothesis that T  cells and macrophages are the pri- 
mary initiators (4, 55). It has been reported that intense cel- 
lular inflammation often precedes Ig deposits along tubular 
basement membranes (56). In addition, T cell lines have been 
isolated that are nephritogenic  upon injection (15). Our results 
thus suggest that B cells may be required for the activation 
of autospecific T cells that infiltrate the kidney. Local cytokine 
release due to glomerular inflammation could also be required 
to promote interstitial inflammation (57). 
The role of Ig in the pathogenesis of vasculitis has been 
controversial  (6-8, 58). Vasculitis was not detected in mice 
lacking B cells, indicating that the vascular lesions were de- 
pendent on either the deposition of Ig or the presence of B 
cells. Definite, but relatively small, quantities of Ig were de- 
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merular immune deposits were abundant; data not shown). 
This observation is consistent with Berden et al. (58),  who 
found Ig within inflammed vessels but not within normal 
vessels of the same MRL-Ipr/Ipr  mice. However, Moyer et 
al. (8) reported that perivascular lymphocytes and macrophages 
were present before vascular immune deposits; antibody depo- 
sition coincided with the development of necrotizing vascu- 
litis in older MRL-Ipr/Ipr  mice. These workers emphasized 
the cell-mediated nature of Ipr/lpr vasculitis.  However, they 
did find B cells in the outer zone of the inflammatory infiltrate. 
Cerny et al. (28) observed that anti-IgM treatment of C57BL/ 
6-1pr/Ipr mice ameliorated nephritis, but did not affect the 
vasculitis, suggesting, in contrast to our results, that B cells/Ig 
are not required for the development of vasculitis. It is difficult 
to reconcile the differences observed between JhD mice and 
anti-IgM treatment. The presence of low levels of B cells, 
heterologous rabbit antiserum, and presumably, immune com- 
plems in the anti-IgM-treated animals may have been sufficient 
to allow for the development of vasculitis.  These potential 
artifacts were not a problem in the JhD mice. Interestingly, 
previous work suggests that the role of B cells in vasculitis 
may differ from that in glomerulonephritis. Genetic (59) and 
passive autoantibody injection studies (18) have suggested that 
vaseulitis and glomerulonephritis can occur and be induced 
separately,  implying that they arise by distinct mechanisms. 
However, further work will be required to distinguish the 
underlying mechanisms. 
Aside from its effect on nephritis, it is interesting that a 
lack of B cells was associated with reduced accumulation of 
T  cells, which was prominent in the older cohort of mice. 
It has been proposed by Huang et al.  (60)  that activation 
of CD4 + and/or CD8 + SP cells is required for accumula- 
tion of DN T  cells. Based on the present data, we propose 
that B cell interaction is an important pathway for such acti- 
vation. Accumulation of both DN  and SP T  cells was re- 
duced in mice lacking B cells, suggesting that B cells either 
interact equally with these subsets to promote their accumu- 
lation or else interact with a precursor that contributes equally 
to these T cell subsets.  T cell accumulation is not, however, 
completely abrogated in the absence of B cells, especially in 
young animals. This suggests that other cell types, perhaps 
dendritic cells or macrophages, are also competent to acti- 
vate precursors of accumulating T  cells. The role of B cells 
in promoting further accumulation would become more ap- 
parent as macrophages and dendritic cells become more lim- 
iting amid the accumulating T cells in mice lacking B cells. 
The requirement for B cells to induce maximal lymphoac- 
cumulation further suggests that theJhs defect prevents an 
apoptotic event, which would normally occur only after T 
cell interaction (either stimulatory or tolerogenic) with an 
APC.  Whether the Jhs deficiency is also required in the B 
cell in order to promote T cell accumulation could be tested 
via reconstitution of B cells in this model system. 
In contrast to the periphery, DN T cells were dispropor- 
tionately overrepresented in the thymi of Ipr/Ipr mice that 
had B cells. This curious observation could be explained by 
either of two mechanisms. First, DN T cells may be gener- 
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ated in the periphery and home to the thymus. The differ- 
ence between B cell-sufticient Ipr/lpr mice and those lacking 
B cells would then be attributed to a difference in the overall 
number of DN T  cells,  which in the mice lacking B cells 
would be two small to permit an "overflow" into the thymus. 
However, young lpr/lpr  mice lacking B cells have as much 
lymphadenopathy as the B cell-sufficient mice, yet have a lower 
proportion of thymic DN T cells. Alternatively, B cells may 
directly affect the generation of some DN  T  cells  in  the 
thymus. This is plausible since small numbers of B cells are 
present in thymus (61). As in the periphery, a lack of B cells 
required for DN T  cell expansion would limit DN T  cell 
generation in the thymus of mice lacking B cells. 
An assumption inherent in our conclusions is  that  the 
phenotypes of homozygous JhD-mutant mice are the result 
of the lack of B cells.  An alternative interpretation is that 
a genetic locus linked to the JhD mutation on chromosome 
12,  rather than the mutation itself, is responsible for our 
findings. A candidate for such a locus, mapped by Watson 
et al. (62) to chromosome 12, modifies Ipr/lpr renal disease 
in the MRL background. Although this locus is linked to 
the Jh locus (most likely ",,40 cM away), it is unlikely that 
it-rather than the Jh knockout itself-is responsible for the 
present observations. The locus described by these workers 
is a "modifying locus" which, along with another unlinked 
locus,  has an effect on the "renal index" that accounts for 
only "~50% of the variance in renal disease. By contrast, the 
difference in nephritis in our studies was dramatic: disease 
was either severe or absent. Thus it is unlikely that this locus 
accounts solely for our observations. The observation that 
Ipr/Ipr mice with either one (i.e., JhD/+) or two (i.e.,  +/+) 
copies of the MILL-derived chromosome 12 had equally se- 
vere disease  also  supports  this conclusion. 
Very recently, Jevnikar et al. (63) have shown that MRL- 
Ipr/Ipr mice that cannot express class II MHC molecules do 
not get nephritis. The authors considered that nephritis was 
abrogated  either  because  of  blocking  of  autoaggressive 
CD4 + T cell generation within the thymus or lack of T cell 
activation within the kidney in the absence of class II expres- 
sion on renal cells. Class II knockout Ipr/Ipr mice lack CD4 + 
T cells, autoantibodies and MHC expression on B cells and 
tissues, complicating interpretation of why these mice do not 
get nephritis. Mice lacking B cells, on the other hand, have 
CD4 + T  cells and can express MHC class II in tissues,  yet 
still do not get nephritis. In light of our data, we suggest 
that in class II-deficient mice, suboptimal B cell activation 
because of lack of class II expression may also play a role in 
preventing nephritis in these mice. Indeed, the MRL-Ipr/Ipr 
class II-deficient mice lacked serum autoantibodies (63).  In 
addition, we would predict that, after restoration of CD4 § 
T cells in these mice through cell transfer, disease would not 
ensue because of the inability to activate B cells. In any case, 
it is of great interest that in both class II-deficient lpr/Ipr mice 
and JhD/JhD Ipr/Ipr mice, B cells are directly affected by the 
genetic alteration,  and nephritis is prevented. 
Our work underscores the importance of B cells in gener- 
ating autoimmune-mediated tissue damage. The results in- 
dicate that B cells are critical for multiple components of autoimmune-mediated inflammation, including those previ- 
ously thought to be primarily mediated by humoral autoim- 
munity (glomerulonephritis), cdlular autoimmunity (inter- 
stitial nephritis) or both (vasculitis). These data demonstrate 
that B cells could be an important target for therapy of sys- 
temic autoimmunity. Elimination of B cells or B cell subsets 
would have distinct advantages over removal of Ig alone (as 
in plasmapheresis).  Pathogenic autoantibodies would be re- 
moved more efficiently than in plasmapheresis;  moreover, 
B cell suppression would also ameliorate immune-mediated 
events requiring cell-cell interaction, such as interstitial ne- 
phritis and vasculitis, which would be unaffected  by removal 
of Ig alone. A better understanding of the role of B cells and 
antibody in inducing autoimmune pathology will be neces- 
sary to design appropriate B cell-directed therapy. 
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